Australian Pot Stocks Soar After Government Relaxes Export Rules
(Bloomberg) -- Australian cannabis stocks more than doubled Thursday, almost matching gains made during the whole of last year, after the government said it would allow exports of medicinal cannabis.
The relaxation of export rules will help shore up the fledgling domestic industry amid increasing competition, Health Minister Greg Hunt said in a statement. A Bloomberg index of local pot stocks based off a gauge from Red Leaf Securities surged 126 percent as of 1:42 p.m. in Sydney, just shy of last year's 132 percent gain.
“It's further vindication that the sector is becoming valid. It's not just a bunch of hippies anymore,” said John Athanasiou, chief executive officer at Red Leaf Securities. “We've just got to be cautious about which ones to pick.”
Shares of companies involved in the cultivation, production and research of medicinal marijuana have been on a tear as regulators relax rules around its use to create a cannabis-derived pharmaceutical industry.
Still, Australia's nascent cannabis sector is a sliver compared to the U.S., where eight states and the District of Columbia have legalized recreational uses of the plant. It's also facing stiff competition from Israel, which is keen to solidify its position as a global center for medical weed research, development and exports.
- Companies in the Australian index, based on a Red Leaf Securities gauge: AC8, BOT, CAN, CPH, ESE, MDC, MMJ, MXC, THC, RGI, ZLD.
To contact the reporter on this story: Matthew Burgess in Sydney at mburgess46@bloomberg.net.
To contact the editors responsible for this story: Edward Johnson at ejohnson28@bloomberg.net, Margo Towie
©2018 Bloomberg L.P.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.